Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes
NCT05612295, Not applicable, Completed, National Taiwan Normal University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes | ClinicalTrials.gov |
| NCT number | NCT05612295 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 97 participants, actual | ClinicalTrials.gov |
| Lead sponsor | National Taiwan Normal University | ClinicalTrials.gov |
| Conditions | Mindfulness, Sport Performance, Neurocognitive Function, Stress | ClinicalTrials.gov |
| Interventions | MBPP, Self-talk | ClinicalTrials.gov |
| First posted | 2022-11-10 | ClinicalTrials.gov |
| Last updated | 2026-03-17 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Endurance performance: Change in time to exhaustion | 30 minutes each at the Baseline-Assessment and at the Post-Assessment | Time to exhaustion (TTE) will be one of the measured variables of endurance performance and be evaluated via a graded exercise test (GXT) on a motor-driven treadmill. | ClinicalTrials.gov |
| Primary | Endurance performance: Change in maximum oxygen consumption | 30 minutes each at the Baseline-Assessment and at the Post-Assessment | Maximum oxygen consumption (VO2max) will be one of the measured variables of endurance performance and be evaluated via a computerized indirect calorimetry system throughout the whole graded exercise test (GXT) on a motor-driven treadmill. | ClinicalTrials.gov |
| Primary | Endocrine stress responses | 1 minutes for each sampling | Before and after pressure manipulation, and after endurance performance measure, stress responses of endocrine assessments will be assessed. Specifically, salivary cortisol (sCort) and salivary alpha-amylases (sAA) will be collected using the commercially available sampling devices. | ClinicalTrials.gov |
| Primary | Subjective stress responses | 5 minutes for each assessment | The participants' subjective perception of stress will be assessed via the Chinese version of the State-Trait Anxiety Inventory (C-STAI) (Wang and Chung, 2016) modified from the original version of STAI (Spielberger et al., 1971). The state subscale of the STAI will be the index of state anxiety influenced by pressure manipulation. | ClinicalTrials.gov |
| Primary | Change in emotion regulation | 10 minutes each at the Baseline-Assessment and at the Post-Assessment | The Chinese version of the Difficulties in Emotion Regulation Scale (C-DERS) modified from DERS (Gratz and Roemer, 2004) will be used to assess emotional regulation. C-DERS is a 36-item self-reported questionnaire to measure the six facets of emotional regulation (i.e., awareness, clarity, impulse, goal, non-acceptance, and strategies). Items are rated on a 5-point Likert scale from 1 (almost never) to 5 (almost always). | ClinicalTrials.gov |
| Primary | Engagement | 5 minutes at the Post-Assessment | Participants' engagement will be an adherence score calculated by addition of the Z scores for overall participant attendance of MBPP/ST sessions and a Z score for overall participant minutes spent on home practice, then divided by the total Z scores. Researchers will record the attendance of each participant in MBPP or ST programs. | ClinicalTrials.gov |
| Primary | Executive function: Change in reaction time | 30 minutes each at the Baseline-Assessment and at the Post-Assessment | The executive function in terms of reaction time will be assessed by the computerized Stroop Test. The types of trials are the three Chinese color words printed in one of the three types of color. Based on the combination of words and the pixels of the color, there are three types of trials: (1) congruent trials: the stimuli in which the color of the word corresponds to the semantic meaning of the word; (2) incongruent trials: the stimuli in which the paint color of the word is inconsistent with the semantic meaning of the word; and (3) neutral trials: the colored squared. | ClinicalTrials.gov |
| Primary | Executive function: Change in accuracy | 30 minutes each at the Baseline-Assessment and at the Post-Assessment | The executive function in terms of accuracy will also be assessed by the computerized Stroop Test. The types of trials are the three Chinese color words printed in one of the three types of color. Based on the combination of words and the pixels of the color, there are three types of trials: (1) congruent trials: the stimuli in which the color of the word corresponds to the semantic meaning of the word; (2) incongruent trials: the stimuli in which the paint color of the word is inconsistent with the semantic meaning of the word; and (3) neutral trials: the colored squared. | ClinicalTrials.gov |
| Primary | Change in attention | 30 minutes each at the Baseline-Assessment and at the Post-Assessment | The attention will be measured by event-related potential while Stroop Test. | ClinicalTrials.gov |
| Primary | Change in brain resting state | 8 minutes each at the Baseline-Assessment and at the Post-Assessment | The frequency domain of electroencephalography (EEG) will also be recorded during the resting state at baseline and post-intervention. | ClinicalTrials.gov |
| Secondary | General dispositional mindfulness | 5 minutes each at the Baseline-Assessment and at the Post-Assessment | The general dispositional mindfulness will be assessed by Chinese version of the Mindful Attention Awareness Scale (C-MAAS)(Chang et al., 2011), which is modified from the original Mindful Attention Awareness Scale (MAAS; Brown \& Ryan, 2003). Higher scores reflect higher levels of general dispositional mindfulness. | ClinicalTrials.gov |
| Secondary | Athletic dispositional mindfulness | 5 minutes each at the Baseline-Assessment and at the Post-Assessment | Athletic mindfulness will be measured by the Athlete Mindfulness Questionnaire (AMQ; Zhang et al., 2017). Higher scores reflect higher levels of athletic dispositional mindfulness. | ClinicalTrials.gov |
| Secondary | Athletic psychological skills | 5 minutes each at the Baseline-Assessment and at the Post-Assessment | Athletic psychological skill levels will be assessed using the Athletic Psychological Skill Inventory (APSI) (Chiou and Chi, 2001), which is a modified Chinese version of Athletic Coping Skills Inventory-28 (ACSI-28; Smith et al., 1995). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 37028503 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)